David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Roivant Sciences
ROIV
$26.3B
| $943K | ﹤0.01% |
+83,684
| New | +$907K |
|
3152
Sportsman's Warehouse
SPWH
$44.1M
| $943K | ﹤0.01% |
273,306
-194,435
| -42% | -$436K |
|
3153
Tigo Energy
TYGO
$80.6M
| $943K | ﹤0.01% |
739,397
-600
| -0.1% | -$584 |
|
3154
National Health Investors
NHI
$3.6B
| $941K | ﹤0.01% |
13,418
+9,981
| +290% | +$731K |
|
|
SKYT
3155
DELISTED
SkyWater Technology
SKYT
| $939K | ﹤0.01% |
95,444
-282,552
| -75% | -$2.28M |
|
3156
Four Corners Property Trust
FCPT
$2.78B
| $939K | ﹤0.01% |
34,877
-63,391
| -65% | -$1.75M |
|
3157
Match Group
MTCH
$9.68B
| $939K | ﹤0.01% |
+30,383
| New | +$909K |
|
3158
CALL
Clorox
CLX
$12.7B
| $937K | ﹤0.01% |
+7,800
| New | +$1.04M |
|
3159
Liberty Latin America Class A
LILA
$1.69B
| $936K | ﹤0.01% |
225,967
-51,461
| -19% | -$186K |
|
3160
iShares MSCI France ETF
EWQ
$338M
| $936K | ﹤0.01% |
+21,871
| New | +$903K |
|
3161
Invesco Aerospace & Defense ETF
PPA
$8.11B
| $935K | ﹤0.01% |
6,597
+1,644
| +33% | +$208K |
|
3162
Avient
AVNT
$4.09B
| $934K | ﹤0.01% |
28,915
-146,271
| -83% | -$5.06M |
|
3163
CALL
Plug Power
PLUG
$3.17B
| $933K | ﹤0.01% |
625,900
-482,100
| -44% | -$481K |
|
3164
CALL
FIVE9
FIVN
$2.41B
| $932K | ﹤0.01% |
35,200
+14,000
| +66% | +$364K |
|
3165
Bridgewater Bancshares
BWB
$589M
| $931K | ﹤0.01% |
58,548
+14,972
| +34% | +$219K |
|
3166
nVent Electric
NVT
$24.5B
| $931K | ﹤0.01% |
12,711
-402,153
| -97% | -$24.7M |
|
3167
Advanced Drainage Systems
WMS
$10.7B
| $929K | ﹤0.01% |
8,092
-94,207
| -92% | -$10.6M |
|
3168
Atlanta Braves Holdings Series A
BATRA
$3.71B
| $929K | ﹤0.01% |
18,876
+3,937
| +26% | +$174K |
|
3169
Resources Connection
RGP
$147M
| $928K | ﹤0.01% |
172,902
-12,807
| -7% | -$69.5K |
|
3170
Taysha Gene Therapies
TSHA
$2.02B
| $927K | ﹤0.01% |
+401,509
| New | +$872K |
|
3171
CALL
Byrna Technologies
BYRN
$87.1M
| $926K | ﹤0.01% |
30,000
+1,500
| +5% | +$36.6K |
|
3172
Forrester Research
FORR
$229M
| $926K | ﹤0.01% |
93,491
-9,060
| -9% | -$90.1K |
|
3173
PUT
Arrowhead Research
ARWR
$12.6B
| $924K | ﹤0.01% |
58,500
+36,900
| +171% | +$529K |
|
|
ONL
3174
Orion Office REIT
ONL
$168M
| $919K | ﹤0.01% |
431,550
-32,710
| -7% | -$62.3K |
|
3175
PUT
Cytokinetics
CYTK
$10.8B
| $919K | ﹤0.01% |
+27,800
| New | +$967K |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.